These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 12154013

  • 1. Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis.
    Miyajima A, Kosaka T, Asano T, Asano T, Seta K, Kawai T, Hayakawa M.
    Cancer Res; 2002 Aug 01; 62(15):4176-9. PubMed ID: 12154013
    [Abstract] [Full Text] [Related]

  • 2. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
    Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S, Kikkawa F.
    Clin Cancer Res; 2005 Apr 01; 11(7):2686-94. PubMed ID: 15814650
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer.
    Kosaka T, Miyajima A, Takayama E, Kikuchi E, Nakashima J, Ohigashi T, Asano T, Sakamoto M, Okita H, Murai M, Hayakawa M.
    Prostate; 2007 Jan 01; 67(1):41-9. PubMed ID: 17044086
    [Abstract] [Full Text] [Related]

  • 4. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis.
    Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M.
    Biochem Biophys Res Commun; 2002 Jun 07; 294(2):441-7. PubMed ID: 12051731
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer.
    Kosugi M, Miyajima A, Kikuchi E, Horiguchi Y, Murai M.
    Clin Cancer Res; 2006 May 01; 12(9):2888-93. PubMed ID: 16675585
    [Abstract] [Full Text] [Related]

  • 6. The tumor suppressive effect of angiotensin II type 1 receptor antagonist in a murine osteosarcoma model.
    Wasa J, Sugiura H, Kozawa E, Kohyama K, Yamada K, Taguchi O.
    Anticancer Res; 2011 Jan 01; 31(1):123-7. PubMed ID: 21273589
    [Abstract] [Full Text] [Related]

  • 7. Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression.
    Ohnuma Y, Toda M, Fujita M, Hosono K, Suzuki T, Ogawa Y, Amano H, Kitasato H, Hayakawa K, Majima M.
    Biomed Pharmacother; 2009 Feb 01; 63(2):136-45. PubMed ID: 18691848
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer.
    Chen X, Meng Q, Zhao Y, Liu M, Li D, Yang Y, Sun L, Sui G, Cai L, Dong X.
    Cancer Lett; 2013 Jan 28; 328(2):318-24. PubMed ID: 23092556
    [Abstract] [Full Text] [Related]

  • 9. Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway.
    Fan F, Tian C, Tao L, Wu H, Liu Z, Shen C, Jiang G, Lu Y.
    Biomed Pharmacother; 2016 Oct 28; 83():704-711. PubMed ID: 27470571
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancer.
    Kosugi M, Miyajima A, Kikuchi E, Kosaka T, Horiguchi Y, Murai M, Oya M.
    Urology; 2009 Mar 28; 73(3):655-60. PubMed ID: 19167032
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth.
    Fujita M, Hayashi I, Yamashina S, Fukamizu A, Itoman M, Majima M.
    Carcinogenesis; 2005 Feb 28; 26(2):271-9. PubMed ID: 15637093
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin system dependence of renal hemodynamics in mice.
    Traynor TR, Schnermann J.
    J Am Soc Nephrol; 1999 Jan 28; 10 Suppl 11():S184-8. PubMed ID: 9892161
    [Abstract] [Full Text] [Related]

  • 14. Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer.
    Kosugi M, Miyajima A, Kikuchi E, Kosaka T, Horiguchi Y, Murai M.
    Hum Cell; 2007 Feb 28; 20(1):1-9. PubMed ID: 17506771
    [Abstract] [Full Text] [Related]

  • 15. Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression.
    Nakamura S, Tsuruma K, Shimazawa M, Hara H.
    Eur J Pharmacol; 2012 Jun 15; 685(1-3):8-14. PubMed ID: 22543084
    [Abstract] [Full Text] [Related]

  • 16. Antagonism of the renin-angiotensin system can counteract cardiac angiogenic vascular endothelial growth factor gene therapy and myocardial angiogenesis in the normal heart.
    Siddiqui AJ, Mansson-Broberg A, Gustafsson T, Grinnemo KH, Dellgren G, Hao X, Fischer H, Sylvén C.
    Am J Hypertens; 2005 Oct 15; 18(10):1347-52. PubMed ID: 16202860
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibitory effects of candesartan on responses to angiotensin peptides in the hindquarters vascular bed of the cat.
    Lambert DG, Champion HC, Kadowitz PJ.
    Can J Physiol Pharmacol; 1998 Feb 15; 76(2):133-40. PubMed ID: 9635151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.